Publication | Open Access

Predictive Model for Infection Risk in Myelodysplastic Syndromes, Acute Myeloid Leukemia, and Chronic Myelomonocytic Leukemia Patients Treated With Azacitidine; Azacitidine Infection Risk Model: The Polish Adult Leukemia Group Study

Hematological MalignancyMyelodysplastic SyndromesAcute Myeloid LeukemiaMixed-phenotype Acute LeukemiaClinical EpidemiologyHematologyMyeloid NeoplasiaHealthcare-associated InfectionInfection ControlPublic HealthMedicineInfection RiskEpidemiologyDrug Resistance